Annual report pursuant to Section 13 and 15(d)

Shareholders Equity (Tables)

v3.20.1
Shareholders Equity (Tables)
 12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Schedule of fair value options granted

    2019     2018  
             
Underlying value of ordinary share ($)     1.7-10       1.7-2  
Exercise price ($)     1.7-10       1.7-2  
Expected volatility (%)     93.1       93.1  
Term of the option (years)     6.25       6.25  
Risk-free interest rate (%)     2.23       2.25-3.05  
Schedule of options to purchase company's ordinary shares

    For year ended December 31,  
    2019  
    Employees     Consultants  
    Number of
Options		     Weighted
average
exercise
price		     Aggregate
intrinsic
value		     Number of
Options		     Weighted
average
exercise
price		     Aggregate
intrinsic
value		  
                                     
Outstanding at the beginning of year     1,868,749       1.58       849       702,388       0.69       944  
Granted     704,699       2.03               79,630       2.03          
Forfeited     (137,682 )     1.90               -                  
Exercised     (74,581 )     1.34               -                  
Outstanding at the end of year     2,361,185       1.87       19,185       782,018       0.82       6,588  
Vested at year end     1,011,862                       470,236                  
Weighted average remaining contractual life – years as of December 31, 2019     8.16                       7.29                  

 

    For year ended December 31,  
    2018  
    Employees     Consultants  
    Number of
Options		     Weighted
average
exercise
price		     Aggregate
intrinsic
value		     Number of
Options		     Weighted
average
exercise
price		     Aggregate
intrinsic
value		  
                                     
Outstanding at the beginning of year     1,278,900       1.29       840       518,442       0.21       915  
Granted     801,310       1.98               183,946       2.03          
Forfeited     (180,523 )     1.63               -                  
Exercised     (30,938 )     (*)               -                  
Outstanding at the end of year     1,868,749       1.58       849       702,388       0.69       944  
Vested at year end     653,201                       323,111                  
Weighted average remaining contractual life – years as of December 31, 2018     8.65                       8.1                  

 

(*) Less than $0.01.
Schedule of share-based payment expenses

    Year ended
December 31,		  
    2019     2018  
    USD In thousands  
             
R&D     450       623  
General and administrative     488       328  
      938       951  
Schedule of outstanding warrants

Warrant   Issuance Date   Expiration Date   Exercise Price
Per Share		     Number of
Shares of
Common Stock
Underlying
Warrants		  
Private Warrants issued to Yeda(see 1 below)   May 11, 2017   May 11, 2025     (*)       591,382  
Private Warrants issued to Founders (see 2 below)   November 27, 2017         -       10,589  
Private Placement Warrants (see 3 below)  

IPO

(December 13, 2018)

   December 13, 2023   $ 11.50       2,900,000  
Public Warrants (see 4 below)  

IPO

(December 13, 2018)

   October 28, 2024   $ 11.50       3,500,000  
                      7,001,971  

 

  (*) less than $0.001.